Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 100.84% is 440% above its 5-year average of -29.70%, near the high end of its 5-year range (-710.12%–273.35%).
15.59% above its 12-month average of 87.24%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 44.96%.
NET PROFIT MARGIN
100.84%
NET PROFIT MARGIN AVG TTM
87.24%
NET PROFIT MARGIN AVG 3Y
7.64%
NET PROFIT MARGIN AVG 5Y
-29.70%
NET PROFIT MARGIN AVG 10Y
-14860.51%
NET PROFIT MARGIN AVG 15Y
-2433.64%
NET PROFIT MARGIN AVG 20Y
-1975.42%
CURRENT VS TTM AVG
+15.59%
CURRENT VS 3Y AVG
+1219.43%
CURRENT VS 5Y AVG
+439.57%
CURRENT VS 10Y AVG
+100.68%
CURRENT VS 15Y AVG
+104.14%
CURRENT VS 20Y AVG
+105.10%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 451 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aurinia Pharmaceuticals Inc.
Market Cap
$2.02B
Net Profit Margin
100.84%
TTM Avg
87.24%
3Y Avg
7.64%
5Y Avg
-29.70%
Market Cap
$2.02B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$2.01B
Net Profit Margin
-3.18%
TTM Avg
-24.20%
3Y Avg
-10.68%
5Y Avg
-8.90%
Market Cap
$2.00B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
Market Cap
$2.05B
Net Profit Margin
15.03%
TTM Avg
11.31%
3Y Avg
2.06%
5Y Avg
-9.89%
Market Cap
$2.06B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
Market Cap
$2.07B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$1.97B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.96B
Net Profit Margin
-15.82%
TTM Avg
-37.57%
3Y Avg
-42.30%
5Y Avg
-41.11%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.02B | 100.84% | 87.24% | 7.64% | -29.70% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -3.18% | -24.20% | -10.68% | -8.90% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.36% | -6.14% | -11.71% | -14.87% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 15.03% | 11.31% | 2.06% | -9.89% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | -40.90% | 5.22% | -37.29% | -215.44% |
| Alvotech (ALVO)vs › | $2.07B | -36.51% | -21.30% | -316.14% | -299.31% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -20.02% | -19.08% | -29.38% | -13.21% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -15.82% | -37.57% | -42.30% | -41.11% |
| Absci Corporation (ABSI)vs › | $1.95B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
Operating Margin
37.1%
Net Profit Margin
100.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 44.96% |
| 2026-03-31 | 44.21% |
| 2025-12-31 | 273.35% |
| 2025-09-30 | 42.95% |
| 2025-06-30 | 30.73% |
| 2025-03-31 | 37.37% |
| 2024-12-31 | 2.39% |
| 2024-09-30 | 21.17% |
| 2024-06-30 | 1.26% |
| 2024-03-31 | -21.37% |
| 2023-12-31 | -59.60% |
| 2023-09-30 | -24.67% |
| 2023-06-30 | -27.70% |
| 2023-03-31 | -76.16% |
| 2022-12-31 | -91.60% |
| 2022-09-30 | -16.12% |
| 2022-06-30 | -125.98% |
| 2022-03-31 | -174.01% |
| 2021-12-31 | -142.38% |
| 2021-09-30 | -342.64% |
| 2021-06-30 | -710.12% |
| 2021-03-31 | -5511.93% |
| 2020-12-31 | -16.14% |
| 2020-09-30 | -145275.86% |
| 2020-06-30 | -91531.03% |
| 2020-03-31 | -86440.00% |
| 2019-12-31 | -263724.14% |
| 2019-09-30 | -8276.96% |
| 2019-06-30 | -54831.03% |
| 2019-03-31 | -41426.67% |
| 2018-12-31 | -50320.69% |
| 2018-09-30 | -4891.20% |
| 2018-06-30 | -54162.07% |
| 2018-03-31 | -51593.33% |
| 2017-12-31 | -10748.39% |
| 2017-09-30 | -45241.38% |
| 2017-06-30 | -729.18% |
| 2017-03-31 | -167551.61% |
| 2016-12-31 | -27776.67% |
| 2016-09-30 | -23932.26% |
| 2016-06-30 | -5956.36% |
| 2016-03-31 | -7485.96% |
| 2015-12-31 | -6907.02% |
| 2015-09-30 | -9043.86% |
| 2015-06-30 | -1242.37% |
| 2015-03-31 | -13872.58% |
| 2014-12-31 | -7233.82% |
| 2014-09-30 | -3500.00% |
| 2014-06-30 | -5657.75% |
| 2014-03-31 | -7747.76% |
| 2013-12-31 | 224.56% |
| 2013-09-30 | -2551.74% |
| 2013-06-30 | -1195.40% |
| 2013-03-31 | -891.02% |
| 2012-12-31 | -5992.96% |
| 2012-09-30 | -1979.07% |
| 2012-06-30 | -2603.36% |
| 2012-03-31 | -7.83% |
| 2011-12-31 | -5277.75% |
| 2011-09-30 | 403.96% |
| 2011-06-30 | 3191.23% |
| 2011-03-31 | -2158.97% |
| 2010-12-31 | -825.73% |
| 2010-09-30 | -569.86% |
| 2010-06-30 | -32.62% |
| 2010-03-31 | 53.93% |
| 2009-12-31 | -97.14% |
| 2009-09-30 | -175.54% |
| 2009-06-30 | -65.74% |
| 2009-03-31 | -505.39% |
| 2008-12-31 | -2352.68% |
| 2008-09-30 | -129.92% |
| 2008-06-30 | -961.24% |
| 2008-03-31 | -921.76% |
| 2007-12-31 | -1395.89% |
| 2007-09-30 | -1338.18% |
| 2007-06-30 | -2171.56% |
| 2007-03-31 | -1109.30% |
| 2006-12-31 | -912.03% |
| 2006-09-30 | -1205.52% |
| 2006-06-30 | -638.51% |
| 2006-03-31 | -335.97% |
| 2005-12-31 | 832.80% |
| 2005-09-30 | -314.20% |
| 2005-06-30 | -3195.22% |
| 2005-03-31 | -2194.79% |
| 2004-12-31 | -3409.38% |
| 2004-09-30 | -2754.69% |
| 2004-06-30 | -1337.35% |
| 2004-03-31 | -620.23% |
| 2003-12-31 | -1097.67% |
| 2003-09-30 | -1506.75% |
| 2003-06-30 | 17.40% |
| 2003-03-31 | -1875.08% |
| 2002-12-31 | -923.96% |
| 2002-09-30 | 59.45% |
